Navigation Links
AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy

Efficacy and Safety of Gene Therapy in Lipoprotein Lipase Deficiency Established

Amsterdam, The Netherlands - May 31, 2007 - Amsterdam Molecular Therapeutics (AMT), a leader in the field of human gene therapy, reported positive Phase I/II clinical trial results with its lead product AMT-010 (now referred to as AMT-011) in Complete Lipoprotein Lipase (LPL) deficient patients at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle. The study's lead investigator is Erik S.G. Stroes, MD, PhD, from the University of Amsterdam Medical Center in The Netherlands.

Ronald Lorijn, CEO of AMT, said, "We believe these excellent results may represent an important milestone for the entire field of gene therapy and for the many patients who today cannot be treated. Our clinical success and the breakthrough in our production platform place us squarely at the forefront of the gene therapy field that is finally coming into its own."

AMT's products rely on a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy to become a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently has a product pipeline with six products at different stages of development.

Study design

The primary goal of the study presented at the ASGT was to investigate if AMT-010 reduces the elevated triglyceride (fat) levels and the associated risk of pancreatitis in Complete LPL deficient patients. The study design was an eight-patient open label dose-escalating study (low and mid dos
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
Post Your Comments:
(Date:6/3/2015)... 3, 2015 The global dermatology treatment devices ... 10.1% from 2014 to 2019. The growth of the ... such as the rising skin disorders, increasing demand for ... factors such as lack of awareness and lack of ... In this report, the global dermatology ...
(Date:6/3/2015)... DIEGO , June 3, 2015  Diomics today ... clandestine service senior official, has joined the company,s board ... of the Intelligence Studies Project and Clinical Professor at ... the University of Texas at Austin. ... from having served 28 years as a member of ...
(Date:6/3/2015)... (NYSE: ACT ), a leading global pharmaceutical company, today ... Actavis, will provide an overview and update of the Company,s ... in Rancho Palos Verdes, Calif. ... presentation will take place on Wednesday, June 10, 2015 at ... Rancho Palos Verdes, Calif.  To access a live ...
Breaking Medicine Technology:Dermatology Treatment Devices Market by Type, by Application - Global Forecast to 2019 2Dermatology Treatment Devices Market by Type, by Application - Global Forecast to 2019 3Former CIA Clandestine Service Senior Official Stephen B. Slick joins Diomics Board of Directors 2Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference 2
... Endo Pharmaceuticals (Nasdaq: ENDP ) today announced ... Food and Drug Administration (FDA) regarding the New Drug Application ... be crush resistant.  The complete response letter did not require ... NDA. "As a result of ongoing discussions ...
... Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR ) announced today ... Conference has been rescheduled for 9:00 a.m. PT on Monday, ... San Francisco. Questcor was originally scheduled to present at 2:00 ... President and Chief Executive Officer, will review the Company,s business ...
Cached Medicine Technology:Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA® ER Designed to be Crush-Resistant 2Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA® ER Designed to be Crush-Resistant 3Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA® ER Designed to be Crush-Resistant 4
(Date:6/3/2015)... MagBelt by Magzook Tightening Systems is now raising funds ... provides a comfortable belt from meetings to mountains. Available in ... 16 color combos to choose from. The MagBelt can also ... , When Denver resident Devin, the creator of MagBelt, realized ... place during long motorcycle rides, he started wondering what else ...
(Date:6/3/2015)... PINES, FL (PRWEB) June 03, 2015 The ... event as part of the Veterans Health Administration’s (VHA) National ... place in the JC Cobb room located on the first ... 10:00 a.m. to 4:00 p.m. Women Veterans and their ... are invited to attend. To download a printable event flyer, ...
(Date:6/3/2015)... 03, 2015 blingsting announces their new ... car's glove compartment or can be strapped onto a ... features a pointed tip that will allow the user ... blade that can cut through a seatbelt or carseat ... Glammer include:, ,         Easily break a window ...
(Date:6/3/2015)... 2015 As of 2014, Japan was ... marketplace. Its share in the Asian market was more ... market in this country is forecast to grow at ... the Asian market is expected to grow at a ... Some of key factors encouraging growth of the marketplace ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Accountable care ... ACO-based insurance products. Despite initial worries that these product ... with consumers, early signs indicate that product-based ACOs will ... offer explanations why in the June issue of Atlantic ... , “I do think anecdotally that the backlash from ...
Breaking Medicine News(10 mins):Health News:MagBelt Starts Kickstarter for Sliding Magnet Belt 2Health News:Bay Pines to Host National Women Veterans Campaign Event June 12 2Health News:Bay Pines to Host National Women Veterans Campaign Event June 12 3Health News:blingsting Announces All New Car Safety Tool The Glammer 2Health News:Asian Pharmacy Information Systems Market to Grow at a 8.3% CAGR through 2019, Says MicroMarketMonitor in its New Report Available at MarketPublishers.com 2Health News:Product-Based ACOs Are Poised for Growth, Industry Observers Tell AIS Newsletter 2Health News:Product-Based ACOs Are Poised for Growth, Industry Observers Tell AIS Newsletter 3
... to avoid harm , , FRIDAY, April 10 (HealthDay News) -- ... recipe for disaster. , The Soap and Detergent Association ... a more effective cleaner, you might be creating a safety ... those made with natural products, could cause harm to the ...
... and mercury exposure , , SATURDAY, April 11 (HealthDay News) -- ... for optimal maternal health and fetal growth and development. That ... how much seafood moms-to-be can safely consume without exposing their ... of ongoing debate. , The U.S. Food and Drug ...
... Manager online scheduling systems during the first quarter of 2009. , ... ... of Aladtec Inc.), a leader in online employee scheduling solutions for the ... and FIRE Manager customers: , , ,Madison County EMS (VA) ,Lehi Fire ...
... April 11 Following is the daily "Profile America" ... http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) SATURDAY, APRIL 11: DONATE LIFEProfile ... month of spring and resurgence. It,s also National ... donation to give a new lease on life to ...
... Ala. Researchers at the University of Alabama at ... $6.4 million grant from two national nonprofit groups that ... difficult-to-treat form of cancer called "triple negative" breast cancer. ... the Cure and the Triple Negative Breast Cancer Foundation. ...
... can have an impact on patients, experts say , , ... emotional burnout called "compassion fatigue" is common among doctors, ... with cancer, yet experts say little research has been ... cynicism, chronic tiredness, irritability and problem drinking. , Often ...
Cached Medicine News:Health News:Cleaning Concoctions Best Left to Experts 2Health News:How Much Fish to Eat While Pregnant? 2Health News:How Much Fish to Eat While Pregnant? 3Health News:Aladtec Inc Announces New Customers for Online Scheduling Systems -- First Quarter, 2009 2Health News:UAB wins $6.4 million nonprofit grant to fight aggressive breast cancer 2Health News:Stressed Health Care Workers Battle 'Compassion Fatigue' 2Health News:Stressed Health Care Workers Battle 'Compassion Fatigue' 3
Egg-Shaped Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be e...
... Discrete Technology Coronary Stent System provides ... Secure Technology stent retention system features ... encapsulate the stent for added security ... to minimize balloon overhang and to ...
Increased stent scaffolding at the proximal end gives optimal lumen support and 6F guide catheter compatibility and improved tracking offer excellent deliverability. Customized balloon lengths for ea...
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
Medicine Products: